MediWound to Report Second Quarter 2024 Financial Results
YAVNE, Israel, Aug. 02, 2024 (GLOBE NEWSWIRE) — MediWound Ltd. (Nasdaq: MDWD), the global leader in next-generation enzymatic therapeutics for […]
Vaxart to Host Second Quarter 2024 Business Update and Financial Results Conference Call on August 8
Conference call to begin at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Aug. 02, 2024 (GLOBE NEWSWIRE) — Vaxart, Inc. […]
Agrify Reminds Stockholders to Vote Before the Proxy Voting Deadline for the Upcoming Annual Meeting of Stockholders
BILLERICA, Mass., Aug. 02, 2024 (GLOBE NEWSWIRE) — Agrify Corporation (Nasdaq:AGFY) (“Agrify” or the “Company”), the most innovative provider of advanced […]
CVRx Announces Increased Inpatient Payment for Barostim Procedure
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) — CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that […]
TSX News -
DIRTT Announces Debenture Repurchase, Enters into Support Agreement and Amends Shareholder Rights Plan
CALGARY, Alberta, Aug. 02, 2024 (GLOBE NEWSWIRE) — DIRTT Environmental Solutions Ltd. (“DIRTT” or the “Company“) (TSX: DRT; OTC: DRTTF), […]
Clip Money and Strategic Treasurer Announce Collaborative Webinar on Tackling Business Deposit Challenges
BOSTON, Aug. 02, 2024 (GLOBE NEWSWIRE) — Clip Money, Inc. (“Clip” or “Company”) (TSXV:CLIP) (OTCQB:CLPMF), a company that operates a […]
Inspire Medical Systems, Inc. Announces FDA Approval of the Inspire V System
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) — Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on […]
Abercrombie & Fitch Co. to Report Second Quarter 2024 Results on August 28, 2024
NEW ALBANY, Ohio, Aug. 02, 2024 (GLOBE NEWSWIRE) — Abercrombie & Fitch Co. (NYSE: ANF) will host its quarterly earnings […]
Arch Biopartners’ Cilastatin Drug Candidate to Participate in the PONTIAC Phase II Trial Targeting Acute Kidney Injury Caused by Drug Toxins
Arch is repurposing cilastatin, a dipeptidase-1 inhibitor, as a new treatment for acute kidney injury (AKI) Cilastatin is particularly well […]
TSX News -
Solaris Completes Socialization of Initial District Exploration Programs
VANCOUVER, British Columbia, Aug. 02, 2024 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) […]
